Aurobindo Pharma subsidiary acquires Khandelwal Laboratories’ non
Published on: Jan. 1, 2026, 6:56 p.m. | Source: CNBC TV18
Aurobindo Pharma Ltd's Auro Pharma acquires Khandelwal Laboratories' non-oncology business, expanding pain management and anti-infective portfolios in India. Shares of Aurobindo Pharma Ltd ended higher on Thursday, January 1, by 1.18% at ₹1,197.00 on the NSE.
